BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 33545400)

  • 1. CD3
    Carpentier C; Schandené L; Dewispelaere L; Heimann P; Cogan E; Roufosse F
    J Allergy Clin Immunol Pract; 2021 Jun; 9(6):2426-2439.e7. PubMed ID: 33545400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mepolizumab as a corticosteroid-sparing agent in lymphocytic variant hypereosinophilic syndrome.
    Roufosse F; de Lavareille A; Schandené L; Cogan E; Georgelas A; Wagner L; Xi L; Raffeld M; Goldman M; Gleich GJ; Klion A
    J Allergy Clin Immunol; 2010 Oct; 126(4):828-835.e3. PubMed ID: 20810155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphocytic variant of hypereosinophilic syndrome: A report of seven cases from a single institution.
    Hu Z; Wang W; Thakral B; Chen Z; Estrov Z; Bueso-Ramos CE; Verstovsek S; Medeiros LJ; Wang SA
    Cytometry B Clin Cytom; 2021 May; 100(3):352-360. PubMed ID: 32157815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The lymphoid variant of hypereosinophilic syndrome: study of 21 patients with CD3-CD4+ aberrant T-cell phenotype.
    Lefèvre G; Copin MC; Staumont-Sallé D; Avenel-Audran M; Aubert H; Taieb A; Salles G; Maisonneuve H; Ghomari K; Ackerman F; Legrand F; Baruchel A; Launay D; Terriou L; Leclech C; Khouatra C; Morati-Hafsaoui C; Labalette M; Borie R; Cotton F; Gouellec NL; Morschhauser F; Trauet J; Roche-Lestienne C; Capron M; Hatron PY; Prin L; Kahn JE;
    Medicine (Baltimore); 2014 Oct; 93(17):255-266. PubMed ID: 25398061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eosinophilia Associated With CD3
    Carpentier C; Verbanck S; Schandené L; Heimann P; Trépant AL; Cogan E; Roufosse F
    Front Immunol; 2020; 11():1765. PubMed ID: 32849632
    [No Abstract]   [Full Text] [Related]  

  • 6. CD3-CD4+ lymphoid variant of hypereosinophilic syndrome: nodal and extranodal histopathological and immunophenotypic features of a peripheral indolent clonal T-cell lymphoproliferative disorder.
    Lefèvre G; Copin MC; Roumier C; Aubert H; Avenel-Audran M; Grardel N; Poulain S; Staumont-Sallé D; Seneschal J; Salles G; Ghomari K; Terriou L; Leclech C; Morati-Hafsaoui C; Morschhauser F; Lambotte O; Ackerman F; Trauet J; Geffroy S; Dumezy F; Capron M; Roche-Lestienne C; Taieb A; Hatron PY; Dubucquoi S; Hachulla E; Prin L; Labalette M; Launay D; Preudhomme C; Kahn JE;
    Haematologica; 2015 Aug; 100(8):1086-95. PubMed ID: 25682606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular profiling of CD3-CD4+ T cells from patients with the lymphocytic variant of hypereosinophilic syndrome reveals targeting of growth control pathways.
    Ravoet M; Sibille C; Gu C; Libin M; Haibe-Kains B; Sotiriou C; Goldman M; Roufosse F; Willard-Gallo K
    Blood; 2009 Oct; 114(14):2969-83. PubMed ID: 19608752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eosinophils affect functions of in vitro-activated human CD3-CD4+ T cells.
    Harfi I; Schandené L; Dremier S; Roufosse F
    J Transl Med; 2013 May; 11():112. PubMed ID: 23642304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hypereosinophilic syndrome associated with CD4+CD3- helper type 2 (Th2) lymphocytes.
    Bank I; Amariglio N; Reshef A; Hardan I; Confino Y; Trau H; Shtrasburg S; Langevitz P; Monselise Y; Shalit M; Rechavi G
    Leuk Lymphoma; 2001 Jun; 42(1-2):123-33. PubMed ID: 11699199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypereosinophilia with abnormal T cells, trisomy 7 and elevated TARC serum level.
    Roumier AS; Grardel N; Laï JL; Becqueriaux I; Ghomari K; de Lavareille A; Roufosse F; Prin L; Capron M
    Haematologica; 2003 Jul; 88(7):ECR24. PubMed ID: 12857571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High serum thymus and activation-regulated chemokine levels in the lymphocytic variant of the hypereosinophilic syndrome.
    de Lavareille A; Roufosse F; Schmid-Grendelmeier P; Roumier AS; Schandené L; Cogan E; Simon HU; Goldman M
    J Allergy Clin Immunol; 2002 Sep; 110(3):476-9. PubMed ID: 12209097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective CD3gamma gene transcription is associated with NFATc2 overexpression in the lymphocytic variant of hypereosinophilic syndrome.
    Willard-Gallo KE; Badran BM; Ravoet M; Zerghe A; Burny A; Martiat P; Goldman M; Roufosse F; Sibille C
    Exp Hematol; 2005 Oct; 33(10):1147-59. PubMed ID: 16219537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eosinophilia associated with clonal T-cell proliferation.
    Kitano K; Ichikawa N; Shimodaira S; Ito T; Ishida F; Kiyosawa K
    Leuk Lymphoma; 1997 Oct; 27(3-4):335-42. PubMed ID: 9402331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New diagnostic tool for differentiation of idiopathic hypereosinophilic syndrome (HES) and secondary eosinophilic states.
    Berki T; Dávid M; Bóné B; Losonczy H; Vass J; Németh P
    Pathol Oncol Res; 2001; 7(4):292-7. PubMed ID: 11882909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The Lymphoid Variant of HES (L-HES) as Differential Diagnose of Severe Asthma in Childhood].
    Leu T; Rauthe S; Wirth C; Simon HU; Kunzmann V; Hebestreit H; Kunzmann S
    Klin Padiatr; 2016 Nov; 228(6-07):319-324. PubMed ID: 27846662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marked and persistent eosinophilia in the absence of clinical manifestations.
    Chen YY; Khoury P; Ware JM; Holland-Thomas NC; Stoddard JL; Gurprasad S; Waldner AJ; Klion AD
    J Allergy Clin Immunol; 2014 Apr; 133(4):1195-202. PubMed ID: 23987798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. JAK inhibition for CD3
    Faguer S; Groh M; Vergez F; Hunault-Berger M; Duployez N; Renaudineau Y; Paul C; Lefevre G; Kahn JE
    Clin Immunol; 2023 Jun; 251():109275. PubMed ID: 36870379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The proportion of CD3- CD4+ T-cell population remained unaffected after corticosteroids treatment for lymphocytic variant hypereosinophilic syndrome (L-HES).
    Helbig G; Wichary R; Razny M; Rodzaj M; Wozniczka K; Dziaczkowska-Suszek J; Kyrcz-Krzemien S
    Scand J Immunol; 2010 Oct; 72(4):372-3. PubMed ID: 20883323
    [No Abstract]   [Full Text] [Related]  

  • 19. Cell clonality in hypereosinophilic syndrome: what pathogenetic role?
    Galimberti S; Ciabatti E; Ottimo F; Rossi A; Trombi L; Carulli G; Cervetti G; Matti L; Bianchi G; Petrini M
    Clin Exp Rheumatol; 2007; 25(1):17-22. PubMed ID: 17417985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 6q- is an early and persistent chromosomal aberration in CD3-CD4+ T-cell clones associated with the lymphocytic variant of hypereosinophilic syndrome.
    Ravoet M; Sibille C; Roufosse F; Duvillier H; Sotiriou C; Schandené L; Martiat P; Goldman M; Willard-Gallo KE
    Haematologica; 2005 Jun; 90(6):753-65. PubMed ID: 15951288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.